Profile
Esper Boel is currently a Director at MonTa Biosciences ApS.
Prior to this, he held positions as Head-Biotechnology Unit at Novo Nordisk A and Senior Vice President & Head-Discovery at Symphogen A. Boel received his undergraduate and doctorate degrees from the University of Aarhus in 1979.
Esper Boel active positions
| Companies | Position | Start |
|---|---|---|
MonTa Biosciences ApS
MonTa Biosciences ApS BiotechnologyHealth Technology Engages in research and development in biotechnology for cancer immunotherapy | Director/Board Member | - |
Former positions of Esper Boel
| Companies | Position | End |
|---|---|---|
Symphogen A/S
Symphogen A/S BiotechnologyHealth Technology Develops antibody therapeutics for the treatment of cancers | Chief Tech/Sci/R&D Officer | - |
| NOVO NORDISK A/S | Corporate Officer/Principal | - |
Training of Esper Boel
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Novo Nordisk A/S
Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care | Health Technology |
University of Aarhus
University of Aarhus Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Symphogen A/S
Symphogen A/S BiotechnologyHealth Technology Develops antibody therapeutics for the treatment of cancers | Health Technology |
MonTa Biosciences ApS
MonTa Biosciences ApS BiotechnologyHealth Technology Engages in research and development in biotechnology for cancer immunotherapy | Health Technology |
- Stock Market
- Insiders
- Esper Boel
















